Search results
Showing 1 to 6 of 6 results for pirtobrutinib
Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6397]
In development Reference number: GID-TA11501 Expected publication date: 24 February 2027
In development Reference number: GID-TA11298 Expected publication date: TBC
Awaiting development Reference number: GID-TA11639 Expected publication date: TBC
Awaiting development Reference number: GID-TA11748 Expected publication date: TBC
Pirtobrutinib for treating relapsed or refractory mantle cell lymphoma [ID3975]
In development Reference number: GID-TA10858 Expected publication date: TBC
New take at home drug recommended for people with chronic lymphocytic leukaemia
Our latest draft guidance recommends pirtobrutinib, a new take at home tablet, that could give patients greater choice and reduce the need for frequent hospital visits.